Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans.

Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans. Cardiovasc Ther. 2012 Dec; 30(6):333-41.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.